CRIP1 and plasma cell myeloma: More recently, CRIP1 has been implicated in several cancers, including hepatocellular carcinoma, acute myeloid leukemia, multiple myeloma, and melanoma, where it can act as either a pro-tumorigenic factor or a tumor suppressor.